Theses, Dissertations, and Capstone Projects

Year of Award

1993

Degree

Master of Business Administration (MBA)

College

College of Business & Professional Studies

Degree Program

Business Administration

Department

Business Administration

Keywords

research, development, dna, GMO, genetically modified, production

Abstract

Biotechnology has come of age. In the span of a decade and half, it has become an integral part of the pharmaceutical sciences, agriculture, environmental science, food science and forensics. Drugs and vaccines once considered farfetched and even impossible are now being developed for commercial application. Pharmacy is poised to be one of the greatest beneficiaries of the current advances of applied biotechnology. One cannot anticipate specifically how disease therapy will be changing as we enter the next century. However, extrapolation from current research-and-development activity suggests that if such biotechnology applications are successful, pharmaceutical intervention will be significantly altered. In agriculture, biotechnology and genetic engineering are expected to change production methods, the products themselves and the structure of the whole agricultural sector.

The purpose of this research paper is to assess the impact of biotechnology on food and pharmaceutical industries. This research paper is divided into five parts. Part I gives an overview of the biotechnology industry and its future. It starts with the evolution of biotechnology and discusses the majors players involved with biotechnology, disciplines involved such as in medicine, pharmaceutical sciences, agriculture, environmental science and food science. It also explores the benefits and value of using new techniques in biotechnology. Part D discusses the problems and opportunities in biotechnology industry which have provided positive changes in the food and pharmaceutical industry such as improving agriculture and food, changes in manufacture of human drugs and benefits of biotechnology in developing countries. Part HI focuses on the commercial value of biotechnology products from investors and industries viewpoints. Part IV examines how the impact of various governmental regulations is promoting the ideal regulatory strategy of preserving the safety of mankind and the environment without hindering unduly the development of new products. It also discusses ethical issues involved in biotechnology and education of the public on new technology. Part V provides a summary and presents the author’s conclusion.

Document Type

Restricted Thesis

Creative Commons License

Creative Commons Attribution-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.

Restricted

Available to Fontbonne users only. Please log in with your id + password.

Free My Thesis

If you are the author of this work and would like to make it openly accessible to all, please click the button above.

Share

COinS